CIPLA.BO
Price:
$1499.7
Market Cap:
$1.21T
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2000-01-03
Stock Exchange
BSE
Ticker
CIPLA.BO
According to Cipla Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.21T. This represents a change of 26.54% compared to the average of 954.68B of the last 4 quarters.
The mean historical Enterprise Value of Cipla Limited over the last ten years is 630.45B. The current 1.21T Enterprise Value has changed 19.06% with respect to the historical average. Over the past ten years (40 quarters), CIPLA.BO's Enterprise Value was at its highest in in the September 2024 quarter at 1.33T. The Enterprise Value was at its lowest in in the December 2024 quarter at 0.
Average
630.45B
Median
547.90B
Minimum
364.29B
Maximum
1.21T
Discovering the peaks and valleys of Cipla Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.77%
Maximum Annual Enterprise Value = 1.21T
Minimum Annual Increase = -22.15%
Minimum Annual Enterprise Value = 364.29B
Year | Enterprise Value | Change |
---|---|---|
2024 | 1.21T | 65.98% |
2023 | 728.47B | -11.70% |
2022 | 825.01B | 23.23% |
2021 | 669.47B | 83.77% |
2020 | 364.29B | -21.05% |
2019 | 461.42B | -7.01% |
2018 | 496.19B | -3.04% |
2017 | 511.74B | 12.55% |
2016 | 454.69B | -22.15% |
2015 | 584.06B | 83.30% |
The current Enterprise Value of Cipla Limited (CIPLA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
920.87B
5-year avg
759.27B
10-year avg
630.45B
Cipla Limited’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipla Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cipla Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cipla Limited's Enterprise Value?
What is the highest Enterprise Value for Cipla Limited (CIPLA.BO)?
What is the 3-year average Enterprise Value for Cipla Limited (CIPLA.BO)?
What is the 5-year average Enterprise Value for Cipla Limited (CIPLA.BO)?
How does the current Enterprise Value for Cipla Limited (CIPLA.BO) compare to its historical average?